Craig L. Leonardi

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Craig L. Leonardi, Alexa B. Kimball, Kim Papp et al. · The Lancet · 2008 · 1.9K citations

Medicine, Dermatology, Immunology +15

Guidelines of care for the management of psoriasis and psoriatic arthritis

Alan Menter, Alice B. Gottlieb, Steven R. Feldman et al. · Journal of the American Academy of Dermatology · 2008 · 1.2K citations

Medicine, Dermatology, Internal Medicine +8

Etanercept as Monotherapy in Patients with Psoriasis

Craig L. Leonardi, JEROLD L. POWERS, Robert Matheson et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Stephen K. Tyring, Alice B. Gottlieb, Kim Papp et al. · The Lancet · 2005 · 1.1K citations

Medicine, Dermatology, Pharmacotherapy +6

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

Craig L. Leonardi, Robert Matheson, Claus Zachariae et al. · New England Journal of Medicine · 2012 · 930 citations · Full text

Medicine, Dermatology, Immunology +17